P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas
卵巢浆液性癌中 P53、MAPK、拓扑异构酶 II α 和 Ki67 免疫组化表达以及 KRAS/BRAF 突变
期刊:Diagnostic Pathology
影响因子:2.3
doi:10.1186/1746-1596-8-21
Sundov, Dinka; Caric, Ana; Mrklic, Ivana; Gugic, Dijana; Capkun, Vesna; Hofman, Irena Drmic; Mise, Branka Petric; Tomic, Snjezana
肿瘤
IHC
肿瘤免疫
BRAF
MAPK/ERK
P53
RAS
免疫/内分泌
